Analysts Set Health Catalyst, Inc. (NASDAQ:HCAT) Price Target at $2.95

Shares of Health Catalyst, Inc. (NASDAQ:HCAT) have earned an average rating of “Hold” from the thirteen research firms that are presently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and four have issued a buy rating on the company. The average 12-month target price among brokers that have covered the stock in the last year is $2.9318.

Several analysts have recently weighed in on the stock. Cantor Fitzgerald reaffirmed a “neutral” rating on shares of Health Catalyst in a report on Monday, May 11th. Canaccord Genuity Group increased their price target on shares of Health Catalyst from $2.00 to $3.00 and gave the stock a “buy” rating in a report on Tuesday, July 21st. Wells Fargo & Company cut their price target on shares of Health Catalyst from $1.75 to $1.50 and set an “equal weight” rating for the company in a report on Thursday. Citigroup reduced their price objective on shares of Health Catalyst from $2.50 to $2.00 and set a “neutral” rating for the company in a research report on Tuesday. Finally, Weiss Ratings raised Health Catalyst from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday, July 28th.

Institutional Trading of Health Catalyst

A number of institutional investors have recently modified their holdings of HCAT. First Light Asset Management LLC grew its holdings in Health Catalyst by 17.2% during the second quarter. First Light Asset Management LLC now owns 12,230,181 shares of the company’s stock worth $46,108,000 after acquiring an additional 1,793,374 shares during the period. Vanguard Group Inc. lifted its holdings in Health Catalyst by 2.9% in the third quarter. Vanguard Group Inc. now owns 4,295,691 shares of the company’s stock valued at $12,243,000 after acquiring an additional 119,117 shares during the period. Whetstone Capital Advisors LLC lifted its holdings in Health Catalyst by 0.5% in the fourth quarter. Whetstone Capital Advisors LLC now owns 3,750,377 shares of the company’s stock valued at $8,963,000 after acquiring an additional 19,027 shares during the period. BlackRock Inc. purchased a new stake in Health Catalyst during the second quarter worth about $3,654,000. Finally, Geode Capital Management LLC boosted its stake in shares of Health Catalyst by 11.4% during the 2nd quarter. Geode Capital Management LLC now owns 1,662,455 shares of the company’s stock worth $6,269,000 after acquiring an additional 169,580 shares in the last quarter. 85.00% of the stock is currently owned by hedge funds and other institutional investors.

Health Catalyst Price Performance

Health Catalyst stock opened at $1.85 on Wednesday. Health Catalyst has a 12 month low of $0.96 and a 12 month high of $3.80. The company has a debt-to-equity ratio of 1.51, a current ratio of 2.70 and a quick ratio of 1.69. The business has a 50 day simple moving average of $2.00 and a 200-day simple moving average of $1.69. The stock has a market capitalization of $139.23 million, a PE ratio of -0.50 and a beta of 1.55.

Health Catalyst (NASDAQ:HCAT) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.04 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.01. The firm had revenue of $70.49 million for the quarter, compared to analyst estimates of $69.09 million. Health Catalyst had a negative net margin of 90.61% and a negative return on equity of 1.83%. Equities analysts predict that Health Catalyst will post -0.25 earnings per share for the current year.

Health Catalyst Company Profile

Health Catalyst (NASDAQ: HCAT) is a healthcare data and analytics technology company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in 2019 and has since focused on delivering a unified data platform that helps healthcare organizations aggregate and analyze clinical, financial and operational information.

The core of Health Catalyst’s offering is the Data Operating System (DOS), a modular data management platform that integrates disparate data sources—from electronic health records to claims and patient-generated data—into a single analytics environment.